These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 140642)

  • 41. Sodium valproate in Sydenham's chorea.
    Dhanaraj M; Radhakrishnan AR; Srinivas K; Sayeed ZA
    Neurology; 1985 Jan; 35(1):114-5. PubMed ID: 3917559
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Isoniazid and Huntington's chorea.
    Perry TL
    N Engl J Med; 1978 May; 298(19):1092-3. PubMed ID: 148007
    [No Abstract]   [Full Text] [Related]  

  • 43. Huntington's disease and HDACi: would sulpiride and valproate be of therapeutic value?
    Tremolizzo L; Rodriguez-Menendez V; DiFrancesco JC; Sala G; Galbussera A; Appollonio I; Ferrarese C
    Med Hypotheses; 2007; 69(4):964-5. PubMed ID: 17428619
    [No Abstract]   [Full Text] [Related]  

  • 44. [Study of the therapeutic action and side-effects of a new preparation of dipropylacetic acid].
    Gallassi R
    Clin Ter; 1977 Nov; 83(3):313-7. PubMed ID: 342177
    [No Abstract]   [Full Text] [Related]  

  • 45. Sodium valproate in Sydenham's chorea.
    Kulkarni ML
    Indian Pediatr; 1992 Mar; 29(3):385-6. PubMed ID: 1612693
    [No Abstract]   [Full Text] [Related]  

  • 46. [Sodium dipropyl acetate in the prevention of febrile convulsions in children].
    Galli V; Gatti G; Massolo F; Nalin A; Rozzi N; Tamborino G
    Acta Neurol (Napoli); 1977; 32(6):884-91. PubMed ID: 343515
    [No Abstract]   [Full Text] [Related]  

  • 47. Sodium valproate in the treatment of intractable seizure disorders: a clinical and electroencephalographic study.
    Adams DJ; Luders H; Pippenger C
    Neurology; 1978 Feb; 28(2):152-7. PubMed ID: 414151
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Modification of personality changes in epileptics using dipropylacetate (Convulex). Preliminary communication].
    Deisenhammer E
    Wien Med Wochenschr; 1977 Jun; 127(12):370-3. PubMed ID: 333779
    [No Abstract]   [Full Text] [Related]  

  • 49. Current concepts in drug therapy.
    Ceylon Med J; 1976 Sep; 21(3):208-9. PubMed ID: 800352
    [No Abstract]   [Full Text] [Related]  

  • 50. Progressive myoclonic epilepsy. The response to sodium di -- n -- propylacetate.
    Tomlinson EB
    Proc Aust Assoc Neurol; 1974; 11():203-8. PubMed ID: 4620029
    [No Abstract]   [Full Text] [Related]  

  • 51. [Use of sodium dipropylacetate in the prevention of recurrences of febrile convulsions].
    Cavazzuti GB
    Riv Neurol; 1977; 47(2):156-8. PubMed ID: 325627
    [No Abstract]   [Full Text] [Related]  

  • 52. [Clinical--pharmacological aspects of treatment with sodium di-n-propylacetate].
    Wulff K; Flachs H; Würtz-Jørgensen A; Gram L
    Ugeskr Laeger; 1977 May; 139(18):1059-64. PubMed ID: 324057
    [No Abstract]   [Full Text] [Related]  

  • 53. [Treatment of pyknoleptic petit mal epilepsy and juvenile myoclonic epilepsy with dipropyl acetate (Deprakine). A pilot study of therapy-resistant patients during control of plasma concentration].
    Schroll M; Naestoft J; Lund M
    Ugeskr Laeger; 1977 May; 139(18):1073-7. PubMed ID: 404744
    [No Abstract]   [Full Text] [Related]  

  • 54. Influence of a GABA transaminase inhibitor on central nervous system oxygen toxicity.
    Harel D; Raday-Bitterman N; Kerem D
    Aviat Space Environ Med; 1978 Jul; 49(7):877-9. PubMed ID: 352331
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Valproate sodium: evaluation of so-called psychotropic effect. A controlled study.
    Sommerbeck KW; Theilgaard A; Rasmussen KE; Lohren V; Gram L; Wulff K
    Epilepsia; 1977 Jun; 18(2):159-67. PubMed ID: 326544
    [No Abstract]   [Full Text] [Related]  

  • 56. [Combined suxilep-depakine (dipropylacetate) therapy in children with suxilep-resistant pyknolepsy].
    Todt H; Wünsche W; Korth G
    Kinderarztl Prax; 1977 Apr; 45(4):175-6. PubMed ID: 406476
    [No Abstract]   [Full Text] [Related]  

  • 57. Choreiform movements associated with the use of valproate.
    Lancman ME; Asconapé JJ; Penry JK
    Arch Neurol; 1994 Jul; 51(7):702-4. PubMed ID: 8018044
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Exceptionally good response to sodium valproate in patients with recurrent Sydenham's chorea].
    Bouchal S; Ouali O; Belahsen MF
    Pan Afr Med J; 2017; 27():212. PubMed ID: 28979614
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Valproate sodium in postanoxic choreoathetosis.
    Giroud M; Dumas R
    J Child Neurol; 1986 Jan; 1(1):80. PubMed ID: 3110259
    [No Abstract]   [Full Text] [Related]  

  • 60. [Clinical study of the normothymic effect of dipropylacetamide].
    Semadeni GW
    Acta Psychiatr Belg; 1976 May; 76(3):458-66. PubMed ID: 798467
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.